Trump Impact on Medicare Drug Price Negotiations Uncertain
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and experimental pricing models for gene therapies. But so far the healthcare elements of the Inflation Reduction Act remain unchanged.
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of prescription drugs.
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The Centers for Medicare & Medicaid Services (CMS) announced that a record-breaking 24.2 million people selected health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback